Literature DB >> 7911243

Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice.

G A Carlson1, C Ebeling, S L Yang, G Telling, M Torchia, D Groth, D Westaway, S J DeArmond, S B Prusiner.   

Abstract

Different prion isolates, often referred to as "strains," present an enigma because considerable evidence argues that prions are devoid of nucleic acid. To investigate prion diversity, we inoculated three "strains" of prions into congenic and transgenic mice harboring variable numbers of two different alleles, designated a and b, of the prion protein (PrP) structural gene, Prn-p. The length of the incubation time was inversely related to the number of Prn-p(a) genes in mice inoculated with the Rocky Mountain Laboratory (RML) prion strain. Results with mice lacking this locus (Prn-p0/0) and transgenic mice argue that long incubation times are not a dominant trait as thought for many years, but rather they are due to reduced levels of the substrate PrPC-A (cellular isoform of PrP, allotype A) in (Prn-p(a) x Prn-pb)F1 mice. In contrast, the Prn-p(a) gene extended incubation times in mice inoculated with the 87V and 22A prion strains, whereas the Prn-pb gene was permissive. Experiments with the 87V isolate suggest that a genetic locus distinct from Prn-p controls deposition of the scrapie isoform of PrP (PrPSc) and attendant neuropathology. Each prion isolate produced distinguishable patterns of PrPSc accumulation in brain; of note, the patterns in Prn-p(a) and Prn-pb congenic mice inoculated with RML prions were more different than those in congenic Prn-pb mice with RML or 22A prions. Our results suggest that scrapie "strain-specific" incubation times can be explained by differences in the relative efficiency of allotypic interactions that lead to conversion of PrPC into PrPSc.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911243      PMCID: PMC44062          DOI: 10.1073/pnas.91.12.5690

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis.

Authors:  K Kellings; N Meyer; C Mirenda; S B Prusiner; D Riesner
Journal:  J Gen Virol       Date:  1992-04       Impact factor: 3.891

2.  A comparison of some biological characteristics of the mouse-passaged scrapie agents, 22A and ME7.

Authors:  A G Dickinson; V M Meikle
Journal:  Genet Res       Date:  1969-04       Impact factor: 1.588

3.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease.

Authors:  M S Palmer; A J Dryden; J T Hughes; J Collinge
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

4.  Linkage of prion protein and scrapie incubation time genes.

Authors:  G A Carlson; D T Kingsbury; P A Goodman; S Coleman; S T Marshall; S DeArmond; D Westaway; S B Prusiner
Journal:  Cell       Date:  1986-08-15       Impact factor: 41.582

5.  Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters.

Authors:  R Hecker; A Taraboulos; M Scott; K M Pan; S L Yang; M Torchia; K Jendroska; S J DeArmond; S B Prusiner
Journal:  Genes Dev       Date:  1992-07       Impact factor: 11.361

6.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

7.  Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters.

Authors:  R A Bessen; R F Marsh
Journal:  J Gen Virol       Date:  1992-02       Impact factor: 3.891

8.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

9.  Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Distinct prion proteins in short and long scrapie incubation period mice.

Authors:  D Westaway; P A Goodman; C A Mirenda; M P McKinley; G A Carlson; S B Prusiner
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

View more
  66 in total

1.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.

Authors:  M Horiuchi; B Caughey
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.

Authors:  L Zulianello; K Kaneko; M Scott; S Erpel; D Han; F E Cohen; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 3.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

4.  Conformational transformation and selection of synthetic prion strains.

Authors:  Sina Ghaemmaghami; Joel C Watts; Hoang-Oanh Nguyen; Shigenari Hayashi; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Mol Biol       Date:  2011-08-04       Impact factor: 5.469

5.  Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.

Authors:  N Nishida; D A Harris; D Vilette; H Laude; Y Frobert; J Grassi; D Casanova; O Milhavet; S Lehmann
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease.

Authors:  Michael D Geschwind; Christopher A Potter; Mamta Sattavat; Paul A Garcia; Howard J Rosen; Bruce L Miller; Stephen J DeArmond
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

7.  Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice.

Authors:  Duo Lu; Kurt Giles; Zhe Li; Satish Rao; Elena Dolghih; Joel R Gever; Michal Geva; Manuel L Elepano; Abby Oehler; Clifford Bryant; Adam R Renslo; Matthew P Jacobson; Stephen J Dearmond; B Michael Silber; Stanley B Prusiner
Journal:  J Pharmacol Exp Ther       Date:  2013-08-21       Impact factor: 4.030

8.  Prion disease: exponential growth requires membrane binding.

Authors:  Daniel L Cox; Rajiv R P Sing; Sichun Yang
Journal:  Biophys J       Date:  2006-03-31       Impact factor: 4.033

9.  Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC.

Authors:  Sandra Müller; Roland Kehm; Michaela Handermann; Nurith J Jakob; Udo Bahr; Björn Schröder; Gholamreza Darai
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

10.  Prion disease tempo determined by host-dependent substrate reduction.

Authors:  Charles E Mays; Chae Kim; Tracy Haldiman; Jacques van der Merwe; Agnes Lau; Jing Yang; Jennifer Grams; Michele A Di Bari; Romolo Nonno; Glenn C Telling; Qingzhong Kong; Jan Langeveld; Debbie McKenzie; David Westaway; Jiri G Safar
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.